Largest study to date of measurable residual disease in autologous hematopoietic cell transplantation for acute myeloid leukemia

Autograft is suboptimal source for acute myeloid leukemia measurable residual disease detection

Granulocyte colony–stimulating factor administration can lead to false-positive Wilms tumor 1 measurable residual disease values.

Measurable residual disease detection by flow cytometry in post–granulocyte colony–stimulating factor autografts is challenging without leukemia-associated immunophenotype

Real-time quantitative PCR for somatic mutations and translocations can improve autograft measurable residual disease detection.